Bi-distinct T cell-participating antibodies (BiTEs) bind each cancer cells and T cells to be able to assistance the immune process answer more promptly and efficiently. Antibody targets below analysis in prostate most cancers medical trials involve: Immunotherapy for prostate cancer contains